STOCK TITAN
  1. Home
  2. Financials
  3. LSBCF
  4. EPS (Diluted)

LakeShore Biopharma Co (LSBCF) EPS by Year

LSBCF

LakeShore Biopharma Co lost $0.73 per diluted share in fiscal year 2025. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters LakeShore Biopharma Co has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.73
Source SEC Filings Latest period FY2025, ended Mar 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LSBCF EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21Filing
EPS (Diluted)-$0.73-$5.71-$3.43-$0.27n/m-$0.47

LSBCF EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'25FilingQ4'24FilingQ4'23FilingQ4'22Filing
EPS (Diluted)N/AN/AN/AN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More LakeShore Biopharma Co financials

Frequently Asked Questions

LakeShore Biopharma Co lost $0.73 per diluted share in fiscal year 2025.

Across the 5 fiscal years this page covers, LakeShore Biopharma Co (LSBCF) diluted earnings per share went from -$0.47 in fiscal year 2021 to -$0.73 in fiscal year 2025.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what LakeShore Biopharma Co (LSBCF) reported on that line in every period on record.